vs
Side-by-side financial comparison of GRID DYNAMICS HOLDINGS, INC. (GDYN) and Pacira BioSciences, Inc. (PCRX). Click either name above to swap in a different company.
Pacira BioSciences, Inc. is the larger business by last-quarter revenue ($196.9M vs $106.2M, roughly 1.9× GRID DYNAMICS HOLDINGS, INC.). On growth, GRID DYNAMICS HOLDINGS, INC. posted the faster year-over-year revenue change (5.9% vs 5.1%). Pacira BioSciences, Inc. produced more free cash flow last quarter ($43.5M vs $6.1M). Over the past eight quarters, GRID DYNAMICS HOLDINGS, INC.'s revenue compounded faster (15.3% CAGR vs 8.5%).
Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.
Pacira BioSciences, Inc. is a specialty pharmaceutical company focused on developing and commercializing non-opioid pain management solutions. Its core product line targets post-surgical pain relief for patients, serving hospitals, ambulatory surgery centers and other healthcare providers primarily in the U.S., with ongoing expansion efforts in select international markets.
GDYN vs PCRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $106.2M | $196.9M |
| Net Profit | $306.0K | — |
| Gross Margin | 34.0% | 79.5% |
| Operating Margin | 0.5% | 1.2% |
| Net Margin | 0.3% | — |
| Revenue YoY | 5.9% | 5.1% |
| Net Profit YoY | -93.2% | — |
| EPS (diluted) | $0.01 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $106.2M | $196.9M | ||
| Q3 25 | $104.2M | $179.5M | ||
| Q2 25 | $101.1M | $181.1M | ||
| Q1 25 | $100.4M | $168.9M | ||
| Q4 24 | $100.3M | $187.3M | ||
| Q3 24 | $87.4M | $168.6M | ||
| Q2 24 | $83.0M | $178.0M | ||
| Q1 24 | $79.8M | $167.1M |
| Q4 25 | $306.0K | — | ||
| Q3 25 | $1.2M | $5.4M | ||
| Q2 25 | $5.3M | $-4.8M | ||
| Q1 25 | $2.9M | $4.8M | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $4.3M | $-143.5M | ||
| Q2 24 | $-817.0K | $18.9M | ||
| Q1 24 | $-3.9M | $9.0M |
| Q4 25 | 34.0% | 79.5% | ||
| Q3 25 | 33.3% | 80.9% | ||
| Q2 25 | 34.1% | 77.4% | ||
| Q1 25 | 36.8% | 79.7% | ||
| Q4 24 | 36.9% | 78.7% | ||
| Q3 24 | 37.4% | 76.9% | ||
| Q2 24 | 35.6% | 75.1% | ||
| Q1 24 | 34.7% | 71.6% |
| Q4 25 | 0.5% | 1.2% | ||
| Q3 25 | -0.2% | 3.5% | ||
| Q2 25 | -0.1% | 4.7% | ||
| Q1 25 | -2.0% | 1.2% | ||
| Q4 24 | 1.3% | 13.2% | ||
| Q3 24 | 2.4% | -82.8% | ||
| Q2 24 | 0.0% | 15.9% | ||
| Q1 24 | -6.9% | 7.9% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 1.1% | 3.0% | ||
| Q2 25 | 5.2% | -2.7% | ||
| Q1 25 | 2.9% | 2.8% | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 4.9% | -85.1% | ||
| Q2 24 | -1.0% | 10.6% | ||
| Q1 24 | -4.9% | 5.4% |
| Q4 25 | $0.01 | $0.05 | ||
| Q3 25 | $0.01 | $0.12 | ||
| Q2 25 | $0.06 | $-0.11 | ||
| Q1 25 | $0.03 | $0.10 | ||
| Q4 24 | $0.06 | $0.38 | ||
| Q3 24 | $0.05 | $-3.11 | ||
| Q2 24 | $-0.01 | $0.39 | ||
| Q1 24 | $-0.05 | $0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $342.1M | $238.4M |
| Total DebtLower is stronger | — | $372.2M |
| Stockholders' EquityBook value | $542.1M | $693.1M |
| Total Assets | $612.9M | $1.3B |
| Debt / EquityLower = less leverage | — | 0.54× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $342.1M | $238.4M | ||
| Q3 25 | $338.6M | $246.3M | ||
| Q2 25 | $336.8M | $445.9M | ||
| Q1 25 | $325.5M | $493.6M | ||
| Q4 24 | $334.7M | $484.6M | ||
| Q3 24 | $231.3M | $453.8M | ||
| Q2 24 | $256.0M | $404.2M | ||
| Q1 24 | $249.4M | $325.9M |
| Q4 25 | — | $372.2M | ||
| Q3 25 | — | $376.7M | ||
| Q2 25 | — | $580.5M | ||
| Q1 25 | — | $583.4M | ||
| Q4 24 | — | $585.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $542.1M | $693.1M | ||
| Q3 25 | $537.7M | $727.2M | ||
| Q2 25 | $532.2M | $757.8M | ||
| Q1 25 | $517.4M | $798.5M | ||
| Q4 24 | $517.8M | $778.3M | ||
| Q3 24 | $400.2M | $749.6M | ||
| Q2 24 | $388.4M | $879.3M | ||
| Q1 24 | $382.8M | $892.2M |
| Q4 25 | $612.9M | $1.3B | ||
| Q3 25 | $613.2M | $1.3B | ||
| Q2 25 | $608.9M | $1.5B | ||
| Q1 25 | $590.9M | $1.6B | ||
| Q4 24 | $592.2M | $1.6B | ||
| Q3 24 | $477.3M | $1.5B | ||
| Q2 24 | $443.6M | $1.6B | ||
| Q1 24 | $435.3M | $1.6B |
| Q4 25 | — | 0.54× | ||
| Q3 25 | — | 0.52× | ||
| Q2 25 | — | 0.77× | ||
| Q1 25 | — | 0.73× | ||
| Q4 24 | — | 0.75× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $43.7M |
| Free Cash FlowOCF − Capex | $6.1M | $43.5M |
| FCF MarginFCF / Revenue | 5.7% | 22.1% |
| Capex IntensityCapex / Revenue | 3.6% | 0.1% |
| Cash ConversionOCF / Net Profit | 32.34× | — |
| TTM Free Cash FlowTrailing 4 quarters | $25.3M | $136.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $43.7M | ||
| Q3 25 | $7.0M | $60.8M | ||
| Q2 25 | $14.4M | $12.0M | ||
| Q1 25 | $9.4M | $35.5M | ||
| Q4 24 | $7.1M | $33.1M | ||
| Q3 24 | $9.2M | $53.9M | ||
| Q2 24 | $10.7M | $53.2M | ||
| Q1 24 | $3.2M | $49.1M |
| Q4 25 | $6.1M | $43.5M | ||
| Q3 25 | $2.9M | $57.0M | ||
| Q2 25 | $10.2M | $9.3M | ||
| Q1 25 | $6.0M | $26.9M | ||
| Q4 24 | $4.4M | $31.0M | ||
| Q3 24 | $5.9M | $49.8M | ||
| Q2 24 | $8.0M | $51.6M | ||
| Q1 24 | $43.0K | $46.3M |
| Q4 25 | 5.7% | 22.1% | ||
| Q3 25 | 2.8% | 31.7% | ||
| Q2 25 | 10.1% | 5.1% | ||
| Q1 25 | 6.0% | 15.9% | ||
| Q4 24 | 4.4% | 16.6% | ||
| Q3 24 | 6.8% | 29.6% | ||
| Q2 24 | 9.7% | 29.0% | ||
| Q1 24 | 0.1% | 27.7% |
| Q4 25 | 3.6% | 0.1% | ||
| Q3 25 | 3.9% | 2.2% | ||
| Q2 25 | 4.1% | 1.5% | ||
| Q1 25 | 3.3% | 5.1% | ||
| Q4 24 | 2.6% | 1.1% | ||
| Q3 24 | 3.7% | 2.4% | ||
| Q2 24 | 3.2% | 0.9% | ||
| Q1 24 | 4.0% | 1.7% |
| Q4 25 | 32.34× | — | ||
| Q3 25 | 5.92× | 11.20× | ||
| Q2 25 | 2.73× | — | ||
| Q1 25 | 3.21× | 7.37× | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 2.15× | — | ||
| Q2 24 | — | 2.82× | ||
| Q1 24 | — | 5.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GDYN
| Other | $30.6M | 29% |
| Technology Media And Telecom | $30.1M | 28% |
| Financial Service | $24.3M | 23% |
| Manufactured Product Other | $10.8M | 10% |
| Related Party | $7.6M | 7% |
| Health Care | $2.8M | 3% |
PCRX
| EXPAREL | $155.8M | 79% |
| ZILRETTA | $33.0M | 17% |
| Iovera | $7.0M | 4% |
